200th Treatment Milestone for AIRFLOW-3 COPD Trial : compare

/PRNewswire/ -- Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, announces two treatment milestones. 200 patients have...

Related Keywords

United States , Brompton , Medway , United Kingdom , London , City Of , Pallav Shah , Prnewswire Nuvaira , Gerard Criner , Professor Of Respiratory Medicine At Imperial College , Nuvaira Inc , Innovatus Capital Partners , Treated Worldwide , Targeted Lung Denervation , Thoracic Medicine , Lewis Katz School , Temple University , Consultant Physician , Royal Brompton Hospitals , Respiratory Medicine , Imperial College , Targeted Lung Denervation System , Nuvaira ,